The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
1
|
L | Antineoplastic and immunomodulating agents | |
2
|
L03 | Immunostimulants | |
3
|
L03A | Immunostimulants | |
4
|
L03AA | Colony stimulating factors | |
5
|
L03AA19 |
| Active Ingredient |
|---|
|
Eflapegrastim-xnst is a recombinant human granulocyte growth factor that binds to G-CSF receptors on myeloid progenitor cells and neutrophils, triggering signaling pathways that control cell differentiation, proliferation, migration and survival. Eflapegrastim-xnst has been shown to elevate neutrophil counts in healthy subjects and in cancer patients. |
| Document | Type | Information Source | |
|---|---|---|---|
| ROLVEDON Solution for injection | MPI, US: SPL/PLR | FDA, National Drug Code (US) |